Prosensa
AcquiredLeiden, Netherlands · Founded 2002 · $30.0M raised
- Headquarters
- Leiden
- Employees
- 51–200
- Founded
- 2002
- Business Model
- B2B
- Website
- prosensa.eu
- Total Funding
- $30.0M
- Last Round
- $30.0M Series CJan 2012
- Rounds
- 2
- Acquired by
- BioMarin Pharmaceutical Inc.Nov 2014
About
Prosensa was a Leiden, Netherlands-based biopharmaceutical company focused on the discovery, development, and commercialization of RNA-modulating therapeutics for rare neuromuscular diseases, particularly Duchenne muscular dystrophy. Founded in 2002, the company went public before being acquired by BioMarin Pharmaceutical in 2014 for approximately $680 million.
Summary
Prosensa is a Biotech company based in Leiden, Netherlands, founded in 2002. It has raised $30.0M in total across 2 rounds, most recently a $30.0M Series C round in Jan 2012. Investors include J.P. Morgan, Citi Ventures and SVB Leerink.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Nov 2014
Sign up to see all 4 rounds
Series B through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/prosensa"><img src="https://indexed.vc/api/badge/company/prosensa" alt="Prosensa on Indexed.vc" width="260" height="76" /></a>